Methylprednisolone Blocks Autoantibody-Induced Tissue Damage in Experimental Models of Bullous Pemphigoid and Epidermolysis Bullosa Acquisita through Inhibition of Neutrophil Activation
Lars Hellberg(Institute of Medical Microbiology and Hygiene), Tamás Laskay(University of Lübeck), Ralf J. Ludwig(University of Lübeck), Werner Solbach(University of Lübeck), Nicole Möckel(University of Lübeck), Tina Beckmann(University of Lübeck), Unni Samavedam(University of Lübeck), Martin Hänsel(University of Lübeck), Wolf‐Henning Boehncke(University Hospital of Geneva), Karoline Holdorf(University of Lübeck), Katja Steinhorst(Goethe University Frankfurt), Tina Kirchner(University of Lübeck), Detlef Zillikens(University of Lübeck), Enno Schmidt(Carrier (United States)), Andreas Recke(University of Lübeck)
Cited by 48
Related Papers
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
|Journal of the American Academy of Dermatology|2008|597
Lymphocyte Circadian Clocks Control Lymph Node Trafficking and Adaptive Immune Responses
|Immunity|2017|461
Cutting Edge: Neutrophil Granulocyte Serves as a Vector for <i>Leishmania</i> Entry into Macrophages
|The Journal of Immunology|2004|429
Diagnosis and management of pemphigus: Recommendations of an international panel of experts
|Journal of the American Academy of Dermatology|2018|384
Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts
|Journal of the American Academy of Dermatology|2011|379